ArticleBMC cardiovascular disorders2025
Prognostic value of left atrioventricular coupling index assessed by 3D echocardiography in patients with chronic kidney disease and heart failure with preserved ejection fraction.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Left atrioventricular coupling index by 2D and 3D echocardiography: association with exercise capacity in chronic kidney disease.Quantitative imaging in medicine and surgery · 2026Article
- Left atrial reservoir strain and the left atrioventricular coupling index in association with left ventricular diastolic dysfunction in non-dialysis chronic kidney disease with preserved ejection fraction: a cross-sectional study.BMC cardiovascular disorders · 2026Article
- Role of imaging techniques in monitoring atrial cardiomyopathy and atrial failure: a scientific statement.ESC heart failure · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveTo evaluate the prognostic value of three-dimensional echocardiography-derived left atrioventricular coupling index (LACI) in patients with chronic kidney disease (CKD) and concomitant heart failure with preserved ejection fraction (HFpEF).
methodsAn analysis of 108 patients with CKD combined with HFpEF was conducted. Participants were categorized into three groups based on LACI, and differences in clinical and echocardiographic characteristics between groups were assessed. Independent associations between LACI and clinical outcomes were assessed using Cox proportional hazards regression modeling. In addition, an analysis was performed to determine the predictive performance of LACI for adverse cardiovascular events by calculating the area under the curve (AUC) and the optimal threshold.
resultsThe median LACI in this study was 0.25. When stratified by tertiles, patients in the high LACI group (> 0.33) were significantly older, had more advanced CKD stages, and had more severe left ventricular diastolic dysfunction (LVDD) (all P < 0.05). With increasing LACI levels, the proportion of grade 1 LVDD progressively decreased while grade 3 LVDD increased (7%, 21%, 58%; P < 0.001). An LACI ≥ 0.235 demonstrated discriminative capability for moderate-to-severe LVDD (AUC = 0.739, P < 0.001). Multivariable Cox proportional hazards regression confirmed LACI as an independent predictor of major clinical outcomes (HR = 1.32, 95% CI: 0.792-0.894, P < 0.001). The optimal cutoff value of 0.26 (AUC = 0.843, P < 0.001) effectively stratified high-risk patients (log-rank P < 0.001). Net reclassification improvement (NRI) analysis demonstrated that incorporating LACI significantly enhanced the incremental predictive value of traditional clinical models.
conclusionLACI, quantified by three-dimensional echocardiography (3DE), correlates with the severity of LVDD. LACI is an independent predictor of adverse clinical outcomes in patients with CKD combined with HFpEF, providing an objective quantitative metric that can guide therapeutic decision-making in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.